Myocarditis: Difference between revisions

 
No edit summary
Line 1: Line 1:
*[[Background|'''Background''']]
*[[Clinical Features|'''Clinical Features''']]
*[[Diagnosis|'''Diagnosis''']]
*[[DDx|'''DDx''']]
*[[Treatment|'''Treatment''']]
*[[Dispo|'''Dispo''']]
*[[See Also|'''See Also''']]
*[[Source|'''Source''']]
== Background  ==
== Background  ==


Line 54: Line 45:
*Fulminant myocarditis has best prognosis  
*Fulminant myocarditis has best prognosis  
*Mortality: 20% 1 yr/ 50% 5 yr  
*Mortality: 20% 1 yr/ 50% 5 yr  
*Children with 70% survival rateat 5 yrs<br>
*Children with 70% survival rateat 5 yrs<br>  
*Complications  
*Complications  
**Vent. Dysrhythmias  
**Vent. Dysrhythmias  

Revision as of 04:05, 5 March 2012

Background

  • An inflammatory cardiomyopathy, under subset of dilated cardiomyopathy caused by necrosis of myocytes from infectious agents, their toxins, and cytotoxic effects of activated host immunity
  • Majority caused by enterovirus (Cocksackie B) and adenovirus. Also influenza A/B, Hep B, B Hemolytic Streptococcus, Mycoplasma, Mumps, CMV and Toxoplasma (cardiac transplant), Chagas (leading cause worldwide) Trichinosis, Diphtheria, Lyme
  • Drugs: Doxorubicin, Cocaine
  • Three phases:
    • Acute: Viral cytotoxicity and focal necrosis
    • Subacute: Host's humoral/immune response leading to further cell injury
    • Chronic: Diffuse myocardial fibrosis and cardiac dysfunction

Clinical Features

  • Typically young/few risk factors for CAD
  • Chest Pain
  • No sensitive symptom or sign but can have flu like syndrome: fever, fatigue, myalgia, N/V; tachycardia (out of proportion to fever), tachypnea, new onset CHF
  • In Peds: grunting, retractions, ronchi. Infants may have fulminant syndrome: Fever, cyanosis, respiratory distress, tachycardia, cardiac failure, ventricular dysrhythmias
  • May have pericardial friction rub

Diagnosis

  • ECG: Sinus tach, low voltages, prolonged QTc, AV block, Acute MI pattern (Usually >1 vessel distribution)
  • TropI: Elevated
  • Echo: Decreased LVEF, global hypokinesis, regional wall motion abnormalities
  • Contrast MR
  • Nuclear Study: Widespread uptake indicating myocyte necrosis
  • Viral titers
  • Endocardial biopsy: Gold standard

DDx

  • Acute MI
  • Pericarditis
  • CHF

Treatment

  • Acute Phase: Antiviral agents may be effective with replicating virus: Pleconaril/Ribavirin
  • Subacute: Studies have not shown efficacy of immunosupressants. Peds: High dose IVIG
  • Chronic: Treat CHF symptoms, Ventricular Assist Devices (VAD), cardiac transplant

Dispo

  • If CHF: Admit to monitored bed; ICU for hemodynamic instability
  • Fulminant myocarditis has best prognosis
  • Mortality: 20% 1 yr/ 50% 5 yr
  • Children with 70% survival rateat 5 yrs
  • Complications
    • Vent. Dysrhythmias
    • LV anneurysm
    • CHF

See Also

Cardiomyopathy

Pericarditis

Source

Rosen's, Tintinalli